Drugs / Inactivated rabies virus vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00842530 Comparator | Feb 2009 → Sep 2013 | Dengue hemorrhagic fever | Sanofi Pasteur, a Sanofi Company | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated rabies virus vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00842530 ↗ |
| Modality | Vaccine | “Biological: Inactivated rabies virus vaccine” NCT00842530 ↗ |
| Route | Subcutaneous | “0.5 mL, Subcutaneous” NCT00842530 ↗ |